{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T08:39:49Z","timestamp":1793176789427,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.clgc.2023.10.006","type":"journal-article","created":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T11:38:03Z","timestamp":1698320283000},"page":"157-163.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Impact of Neoadjuvant Chemotherapy on Pathologic Downstaging in Patients With Variant Histology Undergoing Radical Cystectomy"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0969-6422","authenticated-orcid":false,"given":"Rebecca A.","family":"Campbell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhinav","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Boorjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Knorr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roni","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlo","family":"Nicholas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8202-6268","authenticated-orcid":false,"given":"John","family":"Cheville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3437-9250","authenticated-orcid":false,"given":"Prithvi B.","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Tarrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabin","family":"Thapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew K.","family":"Tollefson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Houston","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.J.","family":"Karnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges Pascal","family":"Haber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8755-9688","authenticated-orcid":false,"given":"Byron","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2023.10.006_bib0001","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.juro.2017.04.086","article-title":"Treatment of non-metastatic muscle-invasive bladder cancer: AUA\/ASCO\/ASTRO\/SUO guideline","volume":"198","author":"Chang","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2023.10.006_bib0002","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","article-title":"European Association of Urology Guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines [internet]","volume":"79","author":"Witjes","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2023.10.006_bib0003","unstructured":"Flaig, T. W., Spiess, P. E., Chair, V., Agarwal, N., Bangs, R., Boorjian, S. A., Buyyounouski, M. K., Chan, K., Chang, S., Downs, T. M., Friedlander, T., Helen Diller Family, U., Greenberg, R. E., Guru, K. A., Guzzo, T., \u03d6, M., Herr, H. W., Hoffman-Censits, J., Inman, B. A., Dwyer, M. (2021). NCCN Guidelines Version 3.2021 Bladder Cancer. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/bladder.pdf. Accessed: May 26, 2021."},{"issue":"4","key":"10.1016\/j.clgc.2023.10.006_bib0004","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.juro.2016.06.049","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline [internet]","volume":"196","author":"Chang","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2023.10.006_bib0005","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2019.08.016","article-title":"European Association of Urology Guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ)\u20142019 update [internet]","volume":"76","author":"Babjuk","year":"2019","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.clgc.2023.10.006_bib0006","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.juro.2012.11.084","article-title":"Plasmacytoid urothelial carcinoma, a chemosensitive cancer with poor prognosis, and peritoneal carcinomatosis [internet]","volume":"189","author":"Dayyani","year":"2013","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.clgc.2023.10.006_bib0007","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.euf.2017.06.013","article-title":"The impact of plasmacytoid variant histology on the survival of patients with urothelial carcinoma of bladder after radical cystectomy [internet]","volume":"5","author":"Li","year":"2019","journal-title":"Eur Urol Focus"},{"issue":"5","key":"10.1016\/j.clgc.2023.10.006_bib0008","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.juro.2012.11.006","article-title":"Outcomes following radical cystectomy for nested variant of urothelial carcinoma: a matched cohort analysis [internet]","volume":"189","author":"Linder","year":"2013","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.clgc.2023.10.006_bib0009","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.humpath.2009.07.015","article-title":"Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 30 pure and mixed cases [internet]","volume":"41","author":"Wasco","year":"2010","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.clgc.2023.10.006_bib0010","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/cncr.22756","article-title":"Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients [internet]","volume":"110","author":"Kamat","year":"2007","journal-title":"Cancer."},{"issue":"5","key":"10.1016\/j.clgc.2023.10.006_bib0011","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/bju.13689","article-title":"Clinical risk stratification in patients with surgically resectable micropapillary bladder cancer [internet]","volume":"119","author":"Fern\u00e1ndez","year":"2017","journal-title":"BJU Int"},{"issue":"8","key":"10.1016\/j.clgc.2023.10.006_bib0012","doi-asserted-by":"crossref","first-page":"E325","DOI":"10.1111\/j.1464-410X.2012.11751.x","article-title":"Pathological response to neoadjuvant chemotherapy for muscle-invasive micropapillary bladder cancer [internet]","volume":"111","author":"Meeks","year":"2013","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.clgc.2023.10.006_bib0013","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00345-012-0976-0","article-title":"Outcomes following radical cystectomy for micropapillary bladder cancer versus pure urothelial carcinoma: a matched cohort analysis [internet]","volume":"30","author":"Wang","year":"2012","journal-title":"World J Urol"},{"issue":"6","key":"10.1016\/j.clgc.2023.10.006_bib0014","first-page":"335","article-title":"Incidence and effect of variant histology on oncological outcomes in patients with bladder cancer treated with radical cystectomy","volume":"35","author":"Moschini","year":"2017","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"10.1016\/j.clgc.2023.10.006_bib0015","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1002\/cncr.30907","article-title":"Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology [internet]","volume":"123","author":"Vetterlein","year":"2017","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.clgc.2023.10.006_bib0016","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.clgc.2019.11.014","article-title":"Neuroendocrine carcinoma of the urinary bladder: a large, retrospective study from the French genitourinary tumor group","volume":"18","author":"Sroussi","year":"2020","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.clgc.2023.10.006_bib0017","series-title":"AJCC Cancer Staging Manual","author":"Amin","year":"2017"},{"key":"10.1016\/j.clgc.2023.10.006_sbref0018","volume":"20","author":"Gu","year":"2020"},{"key":"10.1016\/j.clgc.2023.10.006_bib0019","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1097\/JU.0000000000001855","article-title":"Pathologic downstaging and survival outcomes associated with neoadjuvant chemotherapy for variant histology muscle invasive bladder cancer [internet]","volume":"206","author":"Chakiryan","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2023.10.006_bib0020","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.urology.2019.04.033","article-title":"The complete spectrum of infiltrative renal masses: clinical characteristics and prognostic implications [internet]","volume":"130","author":"Wang","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.clgc.2023.10.006_bib0021","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/JU.0000000000001886","article-title":"Oncologic surveillance for variant histology bladder cancer after radical cystectomy [internet]","volume":"206","author":"Martini","year":"2021","journal-title":"J Urol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767323002288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767323002288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T08:27:57Z","timestamp":1793176077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767323002288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1558767323002288"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2023.10.006","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Neoadjuvant Chemotherapy on Pathologic Downstaging in Patients With Variant Histology Undergoing Radical Cystectomy","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2023.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}